Mantle Ridge
Mantle Ridge's open letter to Air Products shareholders, a week before the vote
Published 16 Jan 2025Available at SEC.gov, link checked 20 Nov 2026Activist letter · Investment
The view as filed on 16 Jan 2025, not a statement of what the author thinks today.
What to notice
- 1
Mantle Ridge rests its final appeal on third-party validation, telling shareholders that ISS, Glass Lewis and Egan-Jones all recommended replacing chief executive Seifi Ghasemi and other directors with its nominees.
Continue the investment thesis
See the 3 remaining takeaways on what this investor is arguing and why, and every analysis across the Letters & Theses library.
Checking what you can open…
“In our experience, shareholder-driven board refreshment has been the only way to effect this outcome.”
Why read it
Shows the last week of a proxy fight at a large industrial company: how an activist uses proxy advisers' verdicts, a named successor and a price target to move votes.
About this letter
Mantle Ridge, an investment firm founded in 2016, sent this open letter to the shareholders of Air Products and Chemicals on 16 January 2025, a week before the industrial gas company's annual meeting on 23 January. Mantle Ridge and its affiliates beneficially owned about $1.3 billion of Air Products' shares and had nominated four directors: Andrew Evans, Paul Hilal, Tracy McKibben and Dennis Reilley. The letter was filed with the SEC the same day on form DFAN14A, inside the press release that announced it, and is signed by the Mantle Ridge team.
It is a closing argument rather than a full case. The letter asks shareholders to vote online in the days left, leans on the recommendations of the three proxy advisory firms, describes what the four nominees would do on a refreshed board, including a new search for a chief executive, and states the value per share Mantle Ridge believes new leadership could unlock. The press release around it adds a short description of how Mantle Ridge says it invests.
Companies
- Air Products and Chemicals APD
- Linde
Themes
- governance
- board change
- management change
- valuation
L3VLUP does not host this document. It belongs to Mantle Ridge and is a public SEC filing; the notes above are L3VLUP’s reading of it.
The same argument, elsewhere
- Broadwood Partners' letter to STAAR Surgical shareholders, against the sale to Alcon · Neal Bradsher, Broadwood Capital
- JANA Partners' second letter to Lamb Weston's board, on what shareholders told it · Scott Ostfeld, JANA Partners
- JANA Partners' letter to the Lamb Weston board on its record and a possible sale · Scott Ostfeld, JANA Partners
- Trian's March 2024 letter to Disney shareholders · Trian Fund Management